Annual Cash & Cash Equivalents
$444.87 M
-$86.82 M-16.33%
December 31, 2023
Summary
- As of February 8, 2025, CVAC annual cash & cash equivalents is $444.87 million, with the most recent change of -$86.82 million (-16.33%) on December 31, 2023.
- During the last 3 years, CVAC annual cash & cash equivalents has fallen by -$1.18 billion (-72.65%).
- CVAC annual cash & cash equivalents is now -72.65% below its all-time high of $1.63 billion, reached on December 31, 2020.
Performance
CVAC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$615.26 M
+$398.18 M+183.43%
September 1, 2024
Summary
- As of February 8, 2025, CVAC quarterly cash and cash equivalents is $615.26 million, with the most recent change of +$398.18 million (+183.43%) on September 1, 2024.
- Over the past year, CVAC quarterly cash and cash equivalents has increased by +$398.18 million (+183.43%).
- CVAC quarterly cash and cash equivalents is now -62.18% below its all-time high of $1.63 billion, reached on December 31, 2020.
Performance
CVAC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CVAC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.3% | +183.4% |
| 3 y3 years | -72.7% | +183.4% |
| 5 y5 years | +1719.0% | +183.4% |
CVAC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | at low | -33.0% | +183.4% |
| 5 y | 5-year | -72.7% | +1194.3% | -62.2% | +1690.0% |
| alltime | all time | -72.7% | +1719.0% | -62.2% | +1690.0% |
CureVac NV Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $615.26 M(+183.4%) |
| Jun 2024 | - | $217.08 M(-33.0%) |
| Mar 2024 | - | $324.13 M(-27.1%) |
| Dec 2023 | $444.87 M(-16.3%) | $444.87 M(-9.4%) |
| Sep 2023 | - | $491.30 M(-16.0%) |
| Jun 2023 | - | $584.58 M(-13.2%) |
| Mar 2023 | - | $673.37 M(+26.6%) |
| Dec 2022 | $531.69 M | $531.69 M(+0.0%) |
| Sep 2022 | - | $531.61 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $599.14 M(-18.4%) |
| Mar 2022 | - | $734.63 M(-20.0%) |
| Dec 2021 | $918.76 M(-43.5%) | $918.76 M(-25.3%) |
| Sep 2021 | - | $1.23 B(-23.7%) |
| Jun 2021 | - | $1.61 B(-0.8%) |
| Dec 2020 | $1.63 B(+4632.8%) | $1.63 B(+55.3%) |
| Sep 2020 | - | $1.05 B(+2085.1%) |
| Mar 2020 | - | $47.95 M(+39.5%) |
| Dec 2019 | $34.37 M(+40.5%) | $34.37 M |
| Dec 2018 | $24.46 M | - |
FAQ
- What is CureVac NV annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CureVac NV?
- What is CureVac NV annual cash & cash equivalents year-on-year change?
- What is CureVac NV quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CureVac NV?
- What is CureVac NV quarterly cash and cash equivalents year-on-year change?
What is CureVac NV annual cash & cash equivalents?
The current annual cash & cash equivalents of CVAC is $444.87 M
What is the all time high annual cash & cash equivalents for CureVac NV?
CureVac NV all-time high annual cash & cash equivalents is $1.63 B
What is CureVac NV annual cash & cash equivalents year-on-year change?
Over the past year, CVAC annual cash & cash equivalents has changed by -$86.82 M (-16.33%)
What is CureVac NV quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CVAC is $615.26 M
What is the all time high quarterly cash and cash equivalents for CureVac NV?
CureVac NV all-time high quarterly cash and cash equivalents is $1.63 B
What is CureVac NV quarterly cash and cash equivalents year-on-year change?
Over the past year, CVAC quarterly cash and cash equivalents has changed by +$398.18 M (+183.43%)